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Disrupted-In-Schizophrenia 1 (DISC1), a strong genetic candidate for psychiatric illness, encodes a multicom-
partmentalized molecular scaffold that regulates interacting proteins with key roles in neurodevelopment and
plasticity. Missense DISC1 variants are associated with the risk of mental illness and with brain abnormalities
in healthy carriers, but the underlying mechanisms are unclear. We examined the effect of rare and common
DISC1 amino acid substitutions on subcellular targeting. We report that both the rare putatively causal vari-
ant 37W and the common variant 607F independently disrupt DISC1 nuclear targeting in a dominant-negative
fashion, predicting that DISC1 nuclear expression is impaired in 37W and 607F carriers. In the nucleus, DISC1
interacts with the transcription factor Activating Transcription Factor 4 (ATF4), which is involved in the regu-
lation of cellular stress responses, emotional behaviour and memory consolidation. At basal cAMP levels,
wild-type DISC1 inhibits the transcriptional activity of ATF4, an effect that is weakened by both 37W and
607F independently, most likely as a consequence of their defective nuclear targeting. The common variant
607F additionally reduces DISC1/ATF4 interaction, which likely contributes to its weakened inhibitory effect.
We also demonstrate that DISC1 modulates transcriptional responses to endoplasmic reticulum stress, and
that this modulatory effect is ablated by 37W and 607F. By showing that DISC1 amino acid substitutions asso-
ciated with psychiatric illness affect its regulatory function in ATF4-mediated transcription, our study high-
lights a potential mechanism by which these variants may impact on transcriptional events mediating
cognition, emotional reactivity and stress responses, all processes of direct relevance to psychiatric illness.
INTRODUCTION
Disrupted-In-Schizophrenia 1 (DISC1) is a risk factor for brain
disorders ranging from depression to schizophrenia (1). DISC1
encodes a multifunctional, multicompartmentalized scaffold
protein with well-established roles in several aspects of neur-
onal physiology, including neural progenitor proliferation, mi-
gration and differentiation, as well as neurotransmission (2).
In the nucleus, DISC1 partially co-localizes with promyelo-
cytic leukaemia nuclear bodies, which identify sites of active
transcription (3), suggesting that DISC1 might be involved
in transcriptional regulation. In support of this, DISC1 can
interact with two highly related stress-responsive transcription
factors, Activating Transcription Factor 4 (ATF4) and Activat-
ing Transcription Factor 5 (ATF5) (3–6), as well as the tran-
scriptional repressor nuclear receptor co-repressor (N-CoR)
(3). The first direct evidence for the involvement of nuclear
DISC1 in transcriptional regulation was provided in a study
by Sawamura et al. (3), who demonstrated that DISC1 can
modulate cAMP-dependent cAMP-response element (CRE)-
mediated transcription by interacting with ATF4.
ATF4 belongs to the activating transcription factor/CRE
binding protein (ATF/CREB) family of basic region-leucine
zipper (bZIP) transcription factors, which share the ability to
bind to the CRE (7). Under basal conditions, ATF4 is
expressed at very low levels, but its transcription and
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translation are rapidly upregulated in response to a range of
different stressors (8). ATF4 can function both as a transcrip-
tional activator and a transcriptional repressor (7). Genes
whose expression is activated by ATF4 include pro- and anti-
apoptotic factors (9,10), as well as genes involved in amino
acid metabolism, regulation of the cell’s redox balance and
mitochondrial function (11). Additionally, ATF4 regulates
emotional behaviour, synaptic plasticity and behavioural
learning (12,13). Indeed, because of its ability to repress the
CREB-mediated late phase of long-term potentiation (LTP)
and long-term memory (LTM) (13), ATF4 has been referred
to as a ‘memory suppressor gene’ (14,15). It is therefore pos-
sible that through its interaction with ATF4, DISC1 might
contribute to the regulation of the transcriptional response to
cellular stress as well as to emotional and LTP-inducing
stimuli.
A number of DISC1 missense variants have been associated
with the increased risk of psychiatric illness, altered brain
morphology or cognitive deficits (1,2), but the molecular
link between structural changes in DISC1 and clinical
outcome has yet to be established. Several risk-conferring mis-
sense variants within DISC1 have the potential to modify the
structure, biochemical properties and subcellular targeting of
the protein, lending support to their putative pathogenic role
(16). In this study, we examined the effect of a spectrum of
common and rare amino acid substitutions of DISC1 asso-
ciated with psychiatric illness on the nuclear targeting of
the protein. We found that both the rare putatively causal
variant 37W and the common 607F substitution impair
nuclear targeting of DISC1, exerting a dominant-negative
effect on the nuclear distribution of wild-type DISC1. Further-
more, the defective nuclear targeting of DISC1 variants 37W
and 607F is reflected in their decreased ability to inhibit
ATF4-dependent transcription. Recently, 607F was shown to
impact on neural development by abrogating DISC1-mediated
activation of wnt-dependent transcription (17). Our findings
add to the evidence for a functional role of 607F in transcrip-
tional regulation, and provide a direct link between risk-
conferring genetic variants and aberrant targeting and function
of nuclear DISC1.
RESULTS
Variants 37W and 607F decrease the nuclear abundance
of DISC1
Several non-synonymous DISC1 variants have been associated
with psychiatric illness and structural brain changes, and some
have been shown to impact on specific aspects of DISC1
biology (1,2,17). Because DISC1 is a multicompartmentalized
protein, we first assessed the impact of a panel of such
disease-associated amino acid substitutions upon its subcellu-
lar distribution. We generated expression constructs (n ¼ 20)
carrying 37W, 432L or 603I (rare/ultra rare) or 607F
(common) variants (1,2,18) in all possible combinations with
the common polymorphisms R264Q and S704C (1,2). With
the exception of R264Q and P432L, all of these DISC1 var-
iants are at highly conserved positions, and all have the poten-
tial to influence the subcellular distribution of DISC1, either
because they are predicted to disrupt critical structural
motifs, or because they occur in regions of DISC1 that
mediate binding to key partner proteins (16).
In a pilot experiment, we used immunocytochemistry to
quantify the relative nuclear abundance of exogenous DISC1
in COS7 cells transfected with either one of the 20 DISC1 ex-
pression constructs. We found no evidence for an effect of
substitutions at positions 264, 432, 603 or 704 on the
nuclear targeting of DISC1 (Supplementary Material,
Fig. S1), nor for gross alteration of the overall subcellular dis-
tribution of DISC1 (not shown). In contrast, both the R37W
and the L607F substitutions result in depletion of exogenous
DISC1 from the nucleus (Supplementary Material, Fig. S1).
Additional variation at positions 264 and 704 does not
modify the effect of 37W or 607F on the nuclear abundance
of DISC1 (Supplementary Material, Fig. S1). These prelimin-
ary observations were confirmed by further immunocytochem-
ical analysis on larger samples of cells (Fig. 1A and B). Both
sequence variants reduce nuclear expression of DISC1 by
50% (P, 0.01). The observed decrease in nuclear expres-
sion of DISC1-37W or DISC1-607F is not due to decreased
overall expression of these DISC1 variants (Supplementary
Material, Fig. S2), which confirms that DISC1 carrying R or
L at positions 37 and 607, respectively, is targeted to the
nucleus more efficiently. DISC1-37W also induces formation
of perinuclear mitochondrial clusters (Fig. 1B), which are
the subject of a separate study (F. Ogawa, unpublished
data). In addition, when compared with wild-type DISC1,
DISC1-607F assumes a more diffuse distribution in the cyto-
plasm (Fig. 1B and Supplementary Material, Fig. S3). Since
we found no evidence for an effect of amino acid variation
at positions 264 and 704 on the subcellular distribution of
DISC1, we performed all the subsequent experiments using
DISC1 constructs encoding the common variants at these posi-
tions (264R and 704S). The common full-length DISC1
variant, to which all other variants analysed here are com-
pared, will henceforth be referred to in the text as ‘wild-type
(WT) DISC1’.
To further examine the effect of DISC1 variants 37W and
607F on the subcellular distribution of the protein, we pre-
pared whole-cell lysates and subcellular protein fractions
from transfected and untransfected SH-SY5Y neuroblastoma
cells and analysed them by western blotting. While the total
protein levels of exogenous wild-type, DISC1-37W and
DISC1-607F were comparable, we detected a 50% decrease
in the relative nuclear abundance of DISC1-37W and
DISC1-607F (P , 0.01, Fig. 1C), and observed a similar
effect by immunocytochemistry (Supplementary Material,
Fig. S4). This reduction in nuclear expression in SH-SY5Y
cells is equivalent to that observed in COS7 cells. Besides
being clearly detectable in the soluble nuclear protein
extract, the full-length 100 kDa DISC1 isoform (both en-
dogenous and exogenous) is also present in the cytoplasmic,
membrane-bound and cytoskeletal extracts, but not in the
chromatin-bound protein fraction (Fig. 1D). While endogen-
ous DISC1 is predominantly enriched in the cytoplasmic and
membrane-associated fractions, the vast majority of exogen-
ous wild-type DISC1 is present in the cytoskeletal fraction
(Fig. 1D). Interestingly, the relative protein abundance
of DISC1-WT, DISC1-37W and DISC1-607F is comparable
in the cytoplasmic and membrane-associated fractions;
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Figure 1. Effect of DISC1 variants on its subcellular distribution. (A) Relative abundance of DISC1 variants in the nucleus of transfected COS7 cells calculated
as the ratio between the total pixel intensity of DISC1 staining in the nucleus and the total pixel intensity of DISC1 staining in the whole cell. The bars represent
the mean values measured in three independent experiments in which 50 cells/variant were analysed. (B) Representative confocal images of COS7 cells expres-
sing wild-type DISC1, DISC1-37W or DISC1-607F. DISC1 is in green, and the nuclei are stained with DAPI (blue). Scale bars are 20 mm. (C) Distribution of
wild-type DISC1, DISC1-37W or DISC1-607F in whole-cell lysates and soluble nuclear extracts (SNE) prepared from transfected SH-SY5Y cells. Each bar
represents the average of four independent experiments. (D) Equal amounts of sub-cellular protein extracts obtained from SH-SY5Y cells that were either
untransfected (bottom) or transfected with wild-type DISC1 (top) were analysed by western blotting using antibodies to detect endogenous or exogenous
DISC1, respectively. ME, membrane extract; CE, cytoplasmic extract; CSKE, cytoskeletal extract; CBNE, chromatin-bound nuclear extract. ∗Non-specific
band. (E) The indicated sub-cellular protein extracts were obtained from SH-SY5Y cells transfected with wild-type, 37W or 607F DISC1 and analysed by
western blotting to detect exogenous DISC1, followed by band densitometry. The loading controls are proteins known to be preferentially enriched in either
of the different subcellular fractions analysed. The bars represent the average of four independent experiments. All the densitometry data are normalized to
the relative band intensity of wild-type DISC1. The position and size (kDa) of the protein markers is indicated.
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however, variant 607F is strongly depleted from the cytoskel-
etal fraction (P , 0.01, Fig. 1E), consistent with its aberrant
cytoplasmic distribution (Fig. 1B and Supplementary Material,
Fig. S3).
Dominant-negative effect of 37W and 607F upon wild-type
DISC1 nuclear distribution
Next, due to the propensity of DISC1 to oligomerize (19–22),
we asked if risk-conferring DISC1 variants 37W and 607F act
in a dominant-negative fashion. Whole-cell lysates and
nuclear protein extracts from SH-SY5Y cells expressing wild-
type DISC1 alone or in combination with either DISC1-37W
or DISC1-607F were analysed by western blotting. We veri-
fied that the different DISC1 expression constructs used in
these experiments achieved comparable levels of protein
expression in SH-SY5Y cells (Supplementary Material,
Fig. S5). As shown in Figure 2A, co-expression of DISC1-
37W or DISC1-607F results in a significant decrease in
nuclear abundance of wild-type DISC1 (P , 0.01), with this
effect being particularly pronounced for the 37W variant
when compared with 607F (P , 0.05). To further examine
this, we co-expressed DISC1-37W or DISC1-607F with wild-
type DISC1 in COS7 and SH-SY5Y cells and analysed the
sub-cellular distribution of each variant by immunocytochem-
istry, using cells transfected with wild-type DISC1 only as a
control. As expected, when wild-type DISC1 is expressed
alone, it translocates to the nucleus, where it is detectable as
numerous bright puncta on a more diffuse background
(Fig. 2B and Supplementary Material, Fig. S6). Consistent
with the results of our subcellular protein fractionation experi-
ment, both DISC1-37W and DISC1-607F reduce the forma-
tion of wild-type DISC1 puncta in the nucleus (Fig. 2B and
Supplementary Material, Fig. S6). Furthermore, we noted
that the cytoplasmic distribution of wild-type DISC1 appears
more diffuse in the majority of cells co-expressing
DISC1-607F (Fig. 2B and Supplementary Material, Fig. S6).
Our results predict that 37W or 607F carriers will have sub-
stantially reduced nuclear DISC1 expression, and that 607F
homozygotes will be similar to 607F heterozygotes in this par-
ticular respect.
Differential effect of DISC1 variants 37W and 607F
on ATF4-mediated transcription
Sawamura et al. (3) showed that co-expression of DISC1
suppresses Gal4-ATF4-mediated transcription and that it
enhances the ATF4-mediated inhibition of CRE-dependent
transcription in response to increased intracellular cAMP
levels. Since ATF4 has also been reported to activate CRE-
mediated transcription under basal (low cAMP) conditions
(23–25), we asked whether DISC1 regulates ATF4-
mediated activation of the CRE at basal cAMP levels. As
expected, in luciferase reporter assays carried out in
HEK293 cells, we detected activation of CRE-driven tran-
scription upon overexpression of ATF4, but not its
dominant-negative mutant ATF4DRK, which lacks the
DNA-binding domain (26,27) (Supplementary Material,
Fig. S7). At basal cAMP levels, co-expression of DISC1
inhibits the ATF4-mediated transactivation of CRE-driven
transcription in a dose-dependent manner (P , 0.01,
Fig. 3A). Importantly, overexpression of DISC1 alone has
no effect on the basal activity of the Som-CRE-luc reporter
(Supplementary Material, Fig. S8), indicating that DISC1
acts via ATF4.
Next, we tested the effect of DISC1 variants 37W and 607F.
Both retain the ability to inhibit ATF4 transcriptional activity,
but their inhibitory effect is significantly weaker compared
with wild-type DISC1 (P, 0.05 for 37W, P, 0.01 for
607F, Fig. 3B). This is not caused by differences in expression
levels (Supplementary Material, Fig. S9) nor it is limited to
HEK293 cells, as we observed this same effect in MO3.13
human oligodendrocytes (P , 0.05 for both variants, Fig. 3C).
The transactivation activity of ATF4 is not limited to CRE-
containing promoters. In fact, several ATF4 target genes
involved in the response to cellular stresses such as amino
acid limitation, oxidative stress or endoplasmic reticulum
stress are activated through C/EBP-ATF Response Elements
(CARE) in their promoters (28). For example, ATF4 induces
expression of its target gene C/EBP homology protein
(CHOP) by binding to a particular type of CARE in its pro-
moter, the Amino Acid Response Element (AARE)
(9,29,30). Thus, we sought to test whether DISC1 modulates
the activity of ATF4 at the CHOP AARE. As expected,
ATF4 strongly activates transcription from a CHOP AARE-
luciferase reporter, but not from its mutant, non-responsive
counterpart (31) (Supplementary Material, Fig. S10). As
with the CRE, wild-type DISC1 significantly represses the
ATF4-dependent transactivation of the CHOP AARE (P,
0.01, Fig. 3D). This inhibitory effect is reduced by
DISC1-607F (P , 0.05, Fig. 3D) and DISC1-37W (P,
0.05, Fig. 3D).
To further investigate the likely relationship between the
decreased ability of DISC1 variants 37W and 607F to inhibit
the transcriptional activity of ATF4 and their defective
nuclear targeting, we tested a mutant form of DISC1 lacking
the predicted leucine zipper in exon 9 (DISC1DLZ9),
located between amino acids 607 and 628. Alanine substitu-
tions at positions 614 and 621 prevent translocation of
DISC1 to the nucleus (3), consistent with LZ9 being required
for nuclear targeting. As expected, when expressed in COS7
cells, DISC1DLZ9 fails to accumulate in the nucleus, and
assumes a diffuse distribution in the cytoplasm (Fig. 4A),
closely resembling that of DISC1-607F (Fig. 1B, Supplemen-
tary Material, Figs S3 and S4). The remarkably similar effects
of 607F and DISC1DLZ9 upon DISC1 nuclear localization are
likely related to the predicted structural disruption of LZ9 by
607F (16). Consistent with its exclusion from the nucleus,
DISC1DLZ9 does not significantly inhibit ATF4-mediated ac-
tivation of CRE-dependent transcription (P, 0.05, Fig. 4B).
ATF4 plays a central role in mediating the cellular response
to a range of damaging stimuli, including endoplasmic reticu-
lum stress (7). Following on from our finding that DISC1
represses the transcriptional activity of exogenous ATF4, we
examined the effect of DISC1 on the transcriptional activity
of endogenously induced ATF4 using the endoplasmic reticu-
lum stress inducer thapsigargin. In line with previously
reported observations (32), thapsigargin treatment induces ex-
pression of endogenous ATF4 (Supplementary Material,
Fig. S11) and determines a 2-fold activation of CRE-
2782 Human Molecular Genetics, 2012, Vol. 21, No. 12
dependent transcription (Fig. 5). Overexpression of wild-type
DISC1, but not variants 37W and 607F or the mutant
DISC1DLZ9, significantly inhibits the thapsigargin-induced
activation of CRE-dependent transcription (Fig. 5).
Morris et al. (4) showed that co-expression of full-length
DISC1 inhibits accumulation of ATF5 in the cell nucleus.
Since ATF4 and ATF5 are structurally closely related (33),
we asked whether DISC1 impacts on the nuclear distribution
and/or protein levels of ATF4, which may contribute to the
observed transcriptional inhibition. Surprisingly, in cells trans-
fected using the same ATF4/DISC1 DNA ratio used in the
luciferase reporter assays, co-expression of DISC1 does not
decrease the overall protein expression or nuclear targeting
of exogenous ATF4, but instead seems to have the opposite
effect, although this does not reach statistical significance
(Fig. 6A and B). DISC1 therefore apparently does not
inhibit ATF4-mediated transcription by reducing nuclear
ATF4 expression.
Although exogenous ATF4 is highly enriched in the
nucleus, we noticed that it is also detectable in the perinuclear
region in a pattern closely resembling the typical morphology
of mitochondria (Fig. 6A), an organelle to which DISC1 is
known to localize (34–36). Cytoplasmic ATF4 partially
co-localizes with exogenous DISC1 in this location
(Fig. 6A). To better test for a potential mitochondrial localiza-
tion of exogenous ATF4, we used four different antibodies to
detect the protein (both tagged and untagged) in transfected
COS7 cells. In each case, we observed partial co-localization
Figure 2. Dominant-negative effect of 37W and 607F DISC1. (A) SH-SY5Y cells were transfected with Flag-WT DISC1 and an equal amount of either
Myc-DISC1-WT, Myc-DISC1-37W or Myc-DISC1-607F. The relative abundance of Flag-WT DISC1 was then quantified by western blotting in whole-cell
lysates and nuclear extracts (NE) prepared from the transfected cells. The bars represent the average of three independent experiments. The data are normalized
to the relative band density of Flag-DISC1 in samples expressing WT DISC1 only. (B) Sub-cellular distribution of Flag-DISC1 (green) and Myc-DISC1 (red) in
representative COS7 cells expressing Flag-WT DISC1 in combination with an equal amount of Myc-DISC1-WT (top), Myc-DISC1-607F (middle) or
Myc-DISC1-37W (bottom). Magnifications of the cell nuclei are shown in the far-right panels. ∗∗P, 0.01; #two-tailed paired Student’s t-test. Scale bars are
20 mm.
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of ATF4 with mitochondria, particularly in the perinuclear
region (Supplementary Material, Fig. S12).
DISC1 variants affect its interaction with ATF4
The L607F substitution is predicted to disrupt the Leucine
packing in DISC1 LZ9, a region identified as essential to
mediate binding to ATF4 (3), and could therefore directly
impair the DISC1–ATF4 interaction. In addition, by introdu-
cing a physical segregation between the two proteins, the defect-
ive nuclear localization of DISC1 variants 37W and 607F might
in itself impair their interaction with ATF4, the majority of
which is found in the nucleus. This mechanism could contribute
to their blunted inhibitory effect on ATF4-mediated transcrip-
tion. As expected, in co-immunoprecipitation assays performed
with exogenous proteins in HEK293 cells, DISC1-607F shows
significantly impaired binding to ATF4 (Fig. 7A). However,
the R37W substitution produces only a slight, non-significant
decrease in DISC1 binding to ATF4 (Fig. 7A).
The observed discrepancy between the defective nuclear
targeting of DISC1-37W and its largely preserved interaction
with ATF4 prompted us to analyse the sub-cellular distribution
of the two proteins in co-transfected cells. Interestingly, unlike
wild-type DISC1 and DISC1-607F, which exhibit limited
co-localization with ATF4 outside the nucleus, DISC1-37W
clearly co-distributes with ATF4 at mitochondria (Fig. 7B).
We therefore conclude that the reduced capacity of DISC1-
37W to inhibit ATF4-mediated transcription is due to its
exclusion from the nucleus, rather than to reduced interaction
with ATF4.
DISCUSSION
Growing evidence indicates that by establishing dynamic
interactions with multiple binding partners, DISC1 functions
as a hub protein whose principal role is to modulate various
cellular processes in a space- and time-regulated manner. Se-
quence changes in DISC1 that disrupt its normal compartmen-
talization and protein interactions are therefore likely to have
functional consequences, and may highlight biological pro-
cesses involved in psychopathology.
In this study, we demonstrated that the putatively causal
variant 37W and the common variant 607F both induce a
50% depletion of the nuclear pool of DISC1, and perturb
Figure 3. Differential effect of DISC1 variants on ATF4-mediated transcription. (A) Relative CRE-dependent luciferase activity in HEK293 cells transfected
with a fixed amount of pCG-ATF4 and decreasing amounts of wild-type DISC1. The numbers indicate the amount (ng/well) of plasmid DNA used for trans-
fection. (B and C) Relative CRE-driven luciferase activity in HEK293 (B) or human oligodendrocyte MO3.13 cells (C) transfected with ATF4 only or in com-
bination with the indicated DISC1 variants. (D) Relative CHOP AARE-driven luciferase activity in HEK293 cells transfected with ATF4 only or in combination
with the indicated DISC1 variants. All data are normalized to the relative luciferase activity in cells transfected with the reporters only (CRE or AARE). The bars
represent the average of at least three independent experiments. ∗P , 0.05, ∗∗P , 0.01.
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the nuclear targeting of wild-type DISC1 in a dominant-
negative fashion. In addition, both variants negatively
impact on the ability of DISC1 to regulate transcription in re-
sponse to exogenous ATF4 and endoplasmic reticulum stress.
37W was identified in a patient diagnosed with schizophrenia
and not in 10 000 control alleles (18), and is thus a rare,
putatively causal variant. In contrast, 607F is a common
variant, present in 10% of the population. The single nucleo-
tide polymorphism (SNP) determining variation at this pos-
ition, or haplotypes including this SNP, is associated with
schizophrenia, schizoaffective disorder, bipolar disorder and
depression and correlate with symptom severity in schizophre-
nia, the P300 waveform mental illness endophenotype and in-
fluence brain structure and function (37–46). Singh et al. (17)
recently assayed several DISC1 variants, including L607F and
two other common variants R264Q and S704C for their effect
on wnt signalling. Interestingly, they reported abnormal wnt
signalling for 264Q and 607F, but not 704C, while we
report abnormal nuclear localization and ATF4 binding for
607F, but not 264Q or 704C, consistent with a differential
effect of non-synonymous amino acid substitutions on the
varied and distinct functions of DISC1.
The 37W sequence change disrupts a highly conserved
tetra-arginine nuclear localization signal in the otherwise
poorly conserved head region of DISC1 (3), while the
common variant 607F is located in a conserved predicted
leucine zipper which was previously shown to contribute to
DISC1 nuclear targeting and to be essential for interaction
with ATF4 (3). The predicted disruption of this leucine
zipper structural feature by L607F (16) therefore likely
explains the reduced nuclear targeting and ATF4 binding of
DISC1-607F, two effects that may potentially be interrelated.
Figure 4. Effect of DISC1 LZ9 on nuclear distribution of DISC1 and transcriptional regulation of ATF4. (A) Confocal image of a representative COS7 cell
expressing DISC1DLZ9 (green). Nuclei are stained with DAPI (blue). (B) Relative luciferase activity in HEK293 cells transfected with the reporters only
(CRE) or in combination with ATF4 with or without wild-type DISC1 or DISC1DLZ9. The bars represent the average of four independent experiments. The
data are normalized to the relative luciferase activity in cells expressing the reporters only (CRE). ∗P , 0.05, two-tailed paired Student’s t-test. The scale
bar is 20 mm.
Figure 5. Effect of DISC1 on the CRE-mediated transcriptional response to
thapsigargin. HEK293 cells were transfected with the reporters only (CRE)
or in combination with the indicated expression constructs. Starting from
32 h post-transfection, the cells were exposed to thapsigargin or vehicle
(DMSO) for the indicated time before being assayed for luciferase activity.
The bars represent the average of at least three independent experiments.
∗∗P, 0.01.
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For both 37W and 607F sequence variants, the end result of
reduced nuclear DISC1 expression most likely explains their
decreased ability to repress ATF4 transcriptional activity.
Depending on the construct tested, DISC1 is capable of
forming dimers, octamers and other oligomers and multimers
(19,20,22,47,48). Thus, in heterozygous cells expressing wild-
type and variant DISC1, hetero/oligomerization will likely
occur, accounting for the dominant-negative effects reported
here. Indeed, we have recently observed that DISC1-37W
recruits wild-type DISC1 to perinuclear mitochondrial aggre-
gates (F. Ogawa, unpublished data). It is therefore possible
that the dominant-negative effect exerted by DISC1-37W on
the nuclear targeting of wild-type DISC1 results from redistri-
bution of wild-type DISC1 to mitochondria. We observed a
significant, but milder reduction in nuclear abundance of wild-
type DISC1 upon co-expression of 607F DISC1, and a change in
the cytoplasmic distribution of wild-type DISC1 from punctate
to diffuse. 607F is located close to a region of DISC1 (668–747)
identified as essential for oligomerization (20) and it resides
within a predicted oligomerization-promoting leucine zipper
(16). Thus, the dominant-negative effect of DISC1-607F on
the nuclear and cytoplasmic distribution of wild-type DISC1
may be related to the potentially altered oligomerization pro-
pensity of this variant form of DISC1. These observations indi-
cate that nuclear expression of wild-type and variant DISC1 will
likely be reduced in 37W or 607F carriers, with consequent
effects for the role of DISC1 in transcription.
ATF4 transcriptional activity is modulated at multiple
levels, including transcription and translation, post-
translational modification and repression of its transcriptional
activity through protein interactions (7,8,23,49–51).
Mammalian cells respond to different types of environmental
stressors by activating distinct stress-responsive kinases, all
converging on phosphorylation of the a subunit of eukaryotic
initiation factor 2 a (eIF2-a) (52). Phosphorylation of eIF2-a
inhibits general protein synthesis while favouring the preferen-
tial translation of ATF4 (11,53,54). The regulation of ATF4
expression in response to stress also occurs at the transcrip-
tional level, with different environmental stressors either acti-
vating or suppressing ATF4 mRNA synthesis (8). At the
post-translational level, ATF4 is regulated by phosphorylation
at multiple sites, which controls both the protein stability by
regulating its ubiquitination (55–57), and its transcriptional
activity (49,51). One further level of control of ATF4
resides in its interaction with binding partners that can directly
inhibit its transcriptional activity, such as CHOP (58), neuron-
al cell death inducible putative kinase (NIPK) (23) and, as we
and others (3) have reported, DISC1. The existence of multiple
mechanisms controlling the production, persistence and activ-
ity of ATF4 indicates the critical importance of tight regula-
tion of ATF4-mediated gene transcription. We and others
(23–25,29,30) have demonstrated that ATF4 activates CRE-
and AARE-mediated transcription at basal cAMP levels,
while, in contrast, ATF4 represses CRE-mediated transcrip-
tion in response to elevated cAMP (3,59). DISC1 inhibits
both the transactivation and repression (3) activities of
ATF4, and is thus likely to be an important modulator of
ATF4-mediated transcription in the brain. Our observation
that the repressive activity of DISC1 is weakened by sequence
variants that influence risk of mental illness suggests that
altered ATF4-mediated transcription may be a contributing
factor to the overall disease risk.
Figure 6. DISC1 does not affect nuclear targeting and protein levels of ATF4. (A) Representative COS7 cells transfected with ATF4 alone (top panels) or in
combination with DISC1 (lower panels). The area delimited by a white rectangle is magnified in the inset. (B) ATF4 protein levels in whole-cell lysates or
nuclear extracts prepared from HEK293 cells transfected with ATF4 alone or in combination with DISC1. The ATF4/DISC1 DNA ratio used in these experi-
ments was the same as that used for the luciferase reporter assays. Loading controls are histone 3 (H3) for whole-cell lysates and nuclear matrix protein p84
for nuclear extracts. The bars represent the average of three independent experiments. Scale bars are 20 mm. The position and size (kDa) of the protein
markers is indicated.
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ATF4 antagonizes the transcriptional activity of CREB, a
key mediator of LTP and LTM (13,15,60,61). Therefore,
through its modulatory effect on ATF4, DISC1 might be
involved in the regulation of the transcriptional events that
mediate synaptic plasticity. This in turn implies that DISC1
variants 37W and 607F may deregulate synaptic plasticity
and cognitive processes through their defective modulation
of ATF4 transcriptional activity. Since cognitive impairment
is a core feature of schizophrenia, this is a potential route by
which these DISC1 variants influence risk of mental illness.
Both DISC1 and ATF4 are implicated in the regulation of
emotional behaviour in rodent models (12,62–67). ATF4 ex-
pression in the nucleus accumbens (NA), a key reward
region in the brain, is induced by amphetamine administration
or restraint stress, and ATF4 overexpression in this region
decreases the behavioural responsiveness to amphetamine
(12). Like its related transcription factor CREB, ATF4 attenu-
ates emotional reactivity and induces depression-like beha-
viours when overexpressed in the NA, clearly indicating that
ATF4 functions as an activator of CRE-driven transcription
Figure 7. Effect of DISC1 variants on the interaction between DISC1 and ATF4. (A) HEK293 cells were transfected with pCG-ATF4 alone or in combination
with the indicated DISC1variants. Exogenous DISC1 was immunoprecipitated using an anti-Flag antibody and detected using an anti-DISC1 antibody
(a-DISC1). Co-precipitating ATF4 was detected with an anti-ATF4 antibody (sc-200). The bars represent the average of three independent experiments.
∗Non-specific band. The position and size (kDa) of the protein markers is indicated. (B) COS7 cells transfected with the indicated variants of DISC1 (green)
and ATF4 (red). The right-hand panels represent the corresponding merged images. The areas delimited by a white square are magnified in the insets. Scale
bars are 20 mm.
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in this brain area (12). Like ATF4, DISC1 modulates the be-
havioural responsiveness to amphetamine in rodent models
(66,68,69), and DISC1 mutations or altered expression are
associated with depression-like behaviours in several mouse
models (62–67). In the light of these findings, it is tempting
to speculate that the role of DISC1 in emotional behaviour
may be at least partly mediated by its modulation of ATF4
transcriptional activity on the CRE. If true, this would imply
that DISC1 variants that interfere with this particular function
of DISC1, such as 37W and 607F, may directly impact on the
regulation of emotional behaviour.
ATF4 is also a key mediator of the integrated stress re-
sponse, and its transcription and translation are strongly upre-
gulated in response to a range of stressors, including amino
acid deprivation, oxidative stress, hypoxia, viral infections,
endoplasmic reticulum stress and mitochondrial dysfunction
(28,70–73). The contribution of damaging environmental
exposures to the risk of developing schizophrenia is well
established, but mechanistically unclear. Maternal starvation,
viral infections and perinatal hypoxia are among the best sup-
ported risk factors for schizophrenia (74), and each of these
exposures could potentially activate the stress responses
mediated by ATF4. It is intriguing to speculate that, by modu-
lating the transcriptional activity of ATF4, DISC1 might con-
tribute to regulation of cellular responses to stress, tipping the
balance towards adaptation or apoptosis. In this scenario, 37W
and 607F substitutions in DISC1 could increase the risk of
mental illness by rendering the brain more susceptible to
stress.
In conclusion, we have identified novel cellular and molecu-
lar phenotypes associated with common and rare DISC1 var-
iants, and highlighted routes by which these psychiatric
illness-associated variants could influence emotional and cog-
nitive processes that are characteristically dysfunctional in
mental illness, and the effects of environmental stressors that
increase the risk of mental illness. Formal testing of gene–
environment interactions has rarely been possible (75), but is
of fundamental importance. Identification of a molecular
mechanism that links the common DISC1 L607F polymorph-
ism to the ATF4-mediated stress response provides an exciting
opportunity to do so in cohorts with appropriate epidemio-
logical data.
MATERIALS AND METHODS
Reagents and antibodies
DMSO and thapsigargin were from Sigma. Primary antibodies
were: anti-Flag (F7425 and F3165) (Sigma), c-Myc (sc-40),
anti-ATF4 (sc-200) (Santa Cruz) and anti-ATF4
(WH0000468M1) (Sigma), a-DISC1 (76), anti-p84 (ab487),
anti-H3 (ab1791), anti-Calreticulin (ab22683), anti-Vimentin
(ab8978) (Abcam) and anti-GAPDH (MAB347) (Millipore).
TO-PRO3 and Mito Tracker Red were from Invitrogen.
Cell culture and transfection
MO3.13 cells (77) were a gift from Adrian Walmsley (Novar-
tis Institute for Biomedical Research, Basel). All cell lines
were cultured in DMEM supplemented with 10% FBS
(Gibco) and maintained in a humidified incubator at 378C
and 5% CO2. Unless otherwise stated, HEK293 and COS7
cells were transfected with Lipofectamine 2000 (Invitrogen)
and SH-SY5Y cells were transfected with FugeneHD
(Roche), according to the manufacturer’s directions.
Plasmids
The ATF4 expression construct pCG-ATF4 (24), encoding
human ATF4, was donated by Adrian Harris (University of
Oxford). pCG-ATF4DRK was obtained by mutating the
DNA-binding domain of human ATF4 in pCG-ATF4
(294RYRQKKR300 to 294GYLEAAA300) by site-directed muta-
genesis. The reporter Som-CRE-luc (Stratagene) and the
TK-Renilla control luciferase vector were gifted by Richard
Killick (King’s College London). The reporter pGL4.23-CRE
was generated by inserting four copies of the Somatostatin
CRE (underlined) and its flanking regions (5′-AGCCTGACGT
CAGAG-3′) upstream of the minimal promoter of the vector
pGL4.23[luc2/minP] (Promega). The reporter vector
pGL4.23-CHOP AARE and its mutant, non-responsive version
pGL4.23-mutCHOP AARE, were generated by site-directed
mutagenesis from pGL4.23[luc2/minP]. Mutagenic primers con-
tained two copies of the core CHOP AARE (underlined) and its
flanking regions: CHOP AARE, 5′-AACATTGCATCATCCCC
GC-3′ and mut CHOP AARE, 5′-AACAATGCATCATCCCC
GC-3′ (31), which only differed for the base in bold. All DISC1
expression constructs were generated from the plasmid
pcDNA4/TO-Flag DISC1, coding for N-terminus Flag-tagged
full-length human DISC1 (isoform L), by site-directed mutagen-
esis. All the site-directed mutagenesis reactions were performed
using the QuikChange II or QuikChange Lightning site-directed
mutagenesis kit (Stratagene), according to the manufacturer’s
directions. All the reporters and expression constructs were veri-
fied by direct sequencing.
Luciferase reporter assays
Most luciferase reporter assays were performed in HEK293
cells because they are a well-characterized model for the
study of the transcriptional effects of ATF4 (30,78) and they
consistently achieve high transfection rates, generating a
strong and replicable luminescence signal. Cells were seeded
in black-walled 96-well plates at a density of 6 × 104/well
(HEK293) or 2.5 × 104/well (MO3.13) and transfected with
Fugene HD (Roche Applied Science) or Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Cells were transfected with 90 ng/well of CRE-luciferase re-
porter plasmid and 9 ng/well of TK Renilla luciferase vector
to control for variation in transfection efficiency. The CRE-
luciferase reporters were Som-CRE-luc for HEK293 cells
and pGL4.23-CRE for MO3.13 cells. The ATF4 expression
plasmids were used at a concentration of 120 ng/well and
15 ng/well for CRE-reporter and CHOP AARE-reporter
assays, respectively. Unless otherwise stated, DISC1 expres-
sion plasmids were used at 81 ng/well. Where necessary, the
empty vector pcDNA4/TO was added to the transfection mix
to bring the total amount of transfected DNA to 300 ng/well.
Background luminescence was measured in cells transfected
with the empty vector pcDNA4/TO, and subtracted from the
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mean readings of each sample. Each transfection was per-
formed in triplicate. Where indicated, drug treatments were
started 32 h after transfection. When DMSO was used as
vehicle, its final concentration in the medium was 0.1% or
lower, and it did not affect cell viability or morphology. Luci-
ferase activity was measured with the Dual Glo Luciferase
Assay System (Promega), following the manufacturer’s proto-
col.
Immunocytochemistry
To stain mitochondria, cells were incubated in 50 nM Mito
Tracker Red in DMEM 10% FBS for 30 min before fixation.
Cells were then fixed in methanol for 5 min at 2208C, fol-
lowed by four washes in cold PBS. Fixed cells were blocked
for 30 min in PBS containing 3% bovine serum albumin
(PBS/BSA), and then incubated for 2 h at room temperature
with the primary antibodies diluted in PBS/BSA. Anti-Flag
antibodies F7425 and F3165 were used at 1:2000 and
1:10.000, respectively. The anti-c-Myc antibody was used at
1:500. The anti-ATF4 antibodies were used at 1:4000
(sc-200) and 1:2.500 (WH0000468M1). Secondary antibodies
were Alexa Fluor goat anti-rabbit IgG 488 and 594 and Alexa
Fluor goat anti-mouse IgG 488 and 594, all used at 1:1000.
TO-PRO3 was used at 1:500. Images were acquired with a
Zeiss LSM510 or a Nikon A1R confocal microscope.
Analysis of DISC1 subcellular distribution
by immunofluorescence
COS7 cells transfected with equal amounts of the indicated
DISC1 expression constructs were stained using an anti-Flag
antibody (F7425) to detect exogenous DISC1, and nuclei
were counterstained with TO-PRO3. Single plane confocal
images of individual transfected cells were acquired using a
Zeiss LSM510 confocal microscope (Zeiss). In each experi-
ment, all the images were acquired using the same confocal
settings. The investigator who acquired the images and per-
formed the analysis was blinded to which variant of DISC1
had been transfected in each cell sample analysed. Image ana-
lysis was performed with IPLab version 3.9.5 r5 (BD Bios-
ciences). For each cell image analysed, the total pixel
intensity of DISC1 staining was measured both in the whole
cell and in the nucleus only. The proportion of DISC1 staining
localized in the nucleus was then calculated as the nucleus/cell
ratio of total pixel intensities in individual cells.
Subcellular fractionation
Subcellular fractions were prepared from SH-SY5Y or
HEK293 cells transfected with the indicated constructs for
72 or 24 h, respectively. In each fractionation experiment, a
small proportion of the cell sample was lysed in RIPA
buffer (150 mM NaCl, 50 mM Tris–HCl, pH 7.5, 1% Nonidet
P-40, 0.1% SDS, 0.5% sodium deoxycholate) supplemented
with a protease inhibitor cocktail (Roche) for subsequent ana-
lysis of the expression level of exogenous proteins by western
blotting. Subcellular fractions were obtained using the Subcel-
lular Protein Fractionation Kit or the NE-PER Nuclear and
Cytoplasmic Extraction Kit (Pierce Thermo Scientific) accord-
ing to the manufacturer’s instructions.
Immunoprecipitation and immunoblotting
For immunoprecipitation, HEK293 cells were lysed in PBS
containing 1% Triton X-100 supplemented with a protease in-
hibitor cocktail (Roche) 24 h after transfection with the indi-
cated plasmids. Immunoprecipitation was performed using
an anti-Flag (F3165) antibody, following a standard protocol
(79). Immunoblotting was performed as described (36).
Chemiluminescent images were captured using the GeneG-
nome imaging system and densitometry was performed
using the Gene Tools software, both from Syngene
(Cambridge, UK). Densitometry was performed in parallel
on duplicate western blots, in a minimum of three independent
experiments. For the western blotting analysis of subcellular
fractions, exogenous DISC1 band densities were first corrected
using appropriate loading controls (nuclear matrix protein p84
for nuclear extracts, GAPDH for cytoplasmic extracts, calreti-
culin for membrane-bound extracts, vimentin for cytoskeletal
extracts), and then divided for the respective GAPDH-
corrected DISC1 band intensities in the corresponding whole-
cell lysates.
Statistical analysis
Unless otherwise specified, data were analysed by one-way
ANOVA followed by Dunnett’s multiple comparison test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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